Non-Disclosure of a Pregnant Woman's HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission.

17:14 EDT 25th October 2014 | BioPortfolio

Summary of "Non-Disclosure of a Pregnant Woman's HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission."

Our objective was to study relations between non-disclosure of HIV to partner, socio demographics and prevention of HIV mother-to-child transmission (PMTCT), among HIV-infected pregnant women enrolled in the French Perinatal Cohort (ANRS-EPF-CO1) from 2005 to 2009 (N = 2,952). Fifteen percent of the women did not disclose their HIV status to their partner. Non-disclosure was more frequent in women diagnosed with HIV infection late in pregnancy, originating from Sub-Saharan Africa or living alone, as well as when the partner was not tested for HIV. Non-disclosure was independently associated with non optimal
PMTCT:
late initiation of antiretroviral therapy, detectable viral load at delivery and lack of neonatal prophylaxis. Nonetheless, the rate of transmission did not differ according to disclosure status. Factors associated with non-disclosure reflect vulnerability and its association with non optimal PMTCT is a cause for concern although the impact on transmission was limited in this context of universal free access to care.

Affiliation

INSERM, UMRS 1018, CESP-HIV/IST Epidemiology, Le Kremlin-Bicêtre, France, carine.jasseron@inserm.fr.

Journal Details

This article was published in the following journal.

Name: AIDS and behavior
ISSN: 1573-3254
Pages:

Links

PubMed Articles [11041 Associated PubMed Articles listed on BioPortfolio]

An unusual cause of dyspnea in a pregnant woman: Supraglottic hemangioma.

Dyspnea is a common complaint among pregnant women; upper airway obstruction is a rare cause of it. We report a case of supraglottic hemangioma in a 20-year-old pregnant woman who presented with incre...

Preferences and related factors for postpartum contraception in pregnant women.

Background: The postpartum period is a time of transition for a pregnant woman and her new family. In this period many pregnant women are in search about the family planning methods. But contraceptive...

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.

Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' ...

HIV knowledge, disclosure and sexual risk among pregnant women and their partners in rural South Africa.

Abstract Partner involvement has been deemed fundamental for the prevention of mother-to-child transmission (PMTCT) of HIV, although it remains difficult to achieve. This study aimed to explore the at...

Severe Herpes Zoster Neuralgia in a Pregnant Woman Treated with Acetaminophen.

There is no recommendation for the treatment of herpes zoster neuralgia in pregnancy, as it even sometimes needs administration of strong opioids. Main observation: Here, we report a pregnant woman wi...

Clinical Trials [2136 Associated Clinical Trials listed on BioPortfolio]

Partner-Assisted Emotional Disclosure for GI Cancer

The long-range goal of this research is to develop better ways of helping GI cancer patients and their caregivers cope more effectively with the demands of the disease. The study is desig...

Ribavirin Pregnancy Registry

Ribavirin should be avoided during pregnancy and during the 6 months before pregnancy in both the female and the male sexual partner. If a pregnancy occurs and is reported to the Ribaviri...

Individuals' Patterns of Disclosure About Huntington's Disease (HD) and the Association With Adaptation to HD

This study will examine the ways in which people reveal their status as a carrier of Huntington's disease (HD) or of being at risk for the disease. It will explore factors that influence d...

Written Self-disclosure for Youth Abdominal Pain

The aims are to evaluate: (1) the effectiveness of written self-disclosure (WSD) on health status of youth ages 12-18 with functional recurrent abdominal pain (RAP); (2) whether effectiven...

Domestic Violence Enhanced Home Visitation Program (DOVE)

DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women a...

Medical and Biotech [MESH] Definitions

The bond or lack thereof between a pregnant woman and her FETUS.

Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)

Surgery performed on the pregnant woman for conditions associated with pregnancy, labor, or the puerperium. It does not include surgery of the newborn infant.

Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.

The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Obstetrics and gynaecology
Latest News Clinical Trials Research Drugs Reports Corporate
Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultants are generalists but the specialty offers a wide range of sub-specialties, which include materno-fetal...

Advertisement